0.5 semaglutide in syringe Syringes and Dosing Wegovy: Package Insert / Prescribing

The metabolic enhancement from glucagon activation combined with appetite suppression from GLP-1 and potential fat distribution benefits from GIP creates multiple layers of weight regulation support

Wegovy was recently approved for the treatment of serious liver disease, known as MASH, in adults with moderate-to-advanced fibrosis

However, GLP-1 medications also have different adverse reactions and contraindications

Once a closely guarded secret among celebrities and the ultra-wealthy, these drugs have become widely accessible in recent years, driving a surge in popularity among those looking to drop pounds

This contraindication applies to all semaglutide products, including compounded versions from licensed 503A compounding pharmacies

Obtain a letter from your prescribing provider stating the medical necessity, your diagnosis, dosage, and expected duration of treatmentthis document increases the likelihood of smooth customs clearance